We generate leads for our subscription business segment from a diverse set of member acquisition channels, which we then seek to convert into members through our contact center, website and other direct-to-consumer activities. These channels include leads from third-parties such as veterinarians and referrals from existing members. Veterinary hospitals represent our largest referral source.
We generate leads for our subscription business segment from a diverse set of member acquisition channels, which we then seek to convert into members through our contact center, website and other direct-to-consumer activities. These channels include referrals from third-parties such as veterinarians and existing members. Veterinary hospitals represent our largest referral source.
We offset sign-up fee revenue because it is a one-time charge to new members collected at the time of enrollment used to partially offset initial setup costs, which are included in new pet acquisition expenses. We exclude other business segment pet acquisition expense because that does not relate to subscription enrollments.
We offset sign-up fee revenue because it is a one-time charge to some new members collected at the time of enrollment used to partially offset initial setup costs, which are included in new pet acquisition expenses. We exclude other business segment pet acquisition expense because that does not relate to subscription enrollments.
Within our subscription business, we also provide "Powered by Trupanion" pet insurance product offerings marketed by third parties, low and medium average revenue per pet products marketed under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland.
Within our subscription business, we also currently provide "Powered by Trupanion" pet insurance product offerings marketed by third parties, low and medium average revenue per pet products marketed under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland.
We offset sign-up fee revenue because it is a one-time charge to new members collected at the time of enrollment used to partially offset initial setup costs, which are included in new pet acquisition expenses.
We offset sign-up fee revenue because it is a one-time charge to some new members collected at the time of enrollment used to partially offset initial setup costs, which are included in new pet acquisition expenses.
While our board of directors has approved the program, any repurchase activity is subject to quarterly assessment and board approval, based on various factors including available cash, our stock price relative to our estimated intrinsic value, forecasted operating results, and available opportunities to deploy capital. We repurchased no shares under this program during the year ended December 31, 2024.
While our board of directors has approved the program, any repurchase activity is subject to quarterly assessment and board approval, based on various factors including available cash, our stock price relative to our estimated intrinsic value, forecasted operating results, and available opportunities to deploy capital. We repurchased no shares under this program during the year ended December 31, 2025.
We have certain contractual obligations in the normal course of business, including obligations and commitments relating to our Credit Facility, non-cancellable vendor purchase agreements, as well as future payments of veterinary invoices. Refer to Note 9, Reserve for Veterinary Invoices, included in Item 8 of Part II of this 10-K, for further details on anticipated cash outflows.
We have certain contractual obligations in the normal course of business, including obligations and commitments relating to our credit arrangements, non-cancellable vendor purchase agreements, as well as future payments of veterinary invoices. Refer to Note 9, Reserve for Veterinary Invoices, included in Item 8 of Part II of this 10-K, for further details on anticipated cash outflows.
We believe the reserve amount as of December 31, 2024 is adequate, and we do not believe that there are any reasonably likely changes in the facts or circumstances underlying key assumptions that would result in the reserve balance being insufficient in an amount that would have a material impact on our reported results, financial position or liquidity.
We believe the reserve amount as of December 31, 2025 is adequate, and we do not believe that there are any reasonably likely changes in the facts or circumstances underlying key assumptions that would result in the reserve balance being insufficient in an amount that would have a material impact on our reported results, financial position or liquidity.
These factors are derived from historical paid loss triangles and reflect observed claim settlement patterns and any operational or external changes affecting claim payments including, but not limited to: • the number of veterinary invoices we expect to receive, • the average cost of those veterinary invoices, • the time elapsed between the date of loss and the date of payment, • the appropriate segmentation between product lines or claim processing method, and • the expected cost to process and administer claim payments As of each reporting date, we also utilize subsequent claims payment activities to monitor and reevaluate previously established reserves.
These factors are derived from historical paid loss triangles and reflect observed claim settlement patterns and any operational or external changes affecting claim payments including, but not limited to: • the number of veterinary invoices we expect to receive, • the average cost of those veterinary invoices, • the time elapsed between the date of loss and the date of payment, • the members chosen deductible, • the appropriate segmentation between product lines or claim processing method, and • the expected cost to process and administer claim payments As of each reporting date, we also utilize subsequent claims payment activities to monitor and reevaluate previously established reserves.
We monitor average monthly retention because it provides a measure of member satisfaction and allows us to calculate the implied average subscriber life in months. 40 Non-GAAP Financial Measures In addition to our results determined in accordance with U.S. GAAP, we believe the following non-GAAP financial measures are useful in evaluating our operating performance.
We monitor average monthly retention because it provides a measure of member satisfaction and allows us to calculate the implied average subscriber life in months. 39 Non-GAAP Financial Measures In addition to our results determined in accordance with U.S. GAAP, we believe the following non-GAAP financial measures are useful in evaluating our operating performance.
Discussions of 2022 items and year-to-year comparisons between 2023 and 2022 that are not included in this Form 10-K can be found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
Discussions of 2023 items and year-to-year comparisons between 2024 and 2023 that are not included in this Form 10-K can be found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
We may enter into additional relationships in this segment in the future, if we believe they will be beneficial, which could impact our operating results. 46 Results of Operations The following tables set forth our results of operations for the periods presented both in absolute dollars and as a percentage of total revenue for those periods.
We may enter into additional relationships in this segment in the future, if we believe they will be beneficial, which could impact our operating results. 45 Results of Operations The following tables set forth our results of operations for the periods presented both in absolute dollars and as a percentage of total revenue for those periods.
We account for such expense as stock-based compensation in accordance with GAAP, but we do not include it in any non-GAAP adjustments. Stock-based compensation associated with bonuses was approximately $0.3 million and $0.7 million for the three months ended December 31, 2024 and 2023, respectively.
We account for such expense as stock-based compensation in accordance with GAAP, but we do not include it in any non-GAAP adjustments. Stock-based compensation associated with bonuses was approximately $0.2 million, $0.3 million and $0.7 million for the three months ended December 31, 2025, 2024 and 2023, respectively.
We monitor monthly average revenue per pet because it is an indicator of the per pet unit economics of our subscription business. 39 Average pet acquisition cost. Average pet acquisition cost ("PAC") is calculated as net acquisition cost divided by the total number of new subscription pets enrolled in that period.
We monitor monthly average revenue per pet because it is an indicator of the per pet unit economics of our subscription business. 38 Average pet acquisition cost. Average pet acquisition cost ("PAC") is calculated as net acquisition cost divided by the total number of new subscription pets enrolled in that period.
Cost of Revenue Cost of revenue in each of our segments is comprised of the following: Veterinary invoice expense Veterinary invoice expense includes our costs to review and pay veterinary invoices, administer the payments, and provide member services, and other operating expenses directly or indirectly related to the claims process.
Cost of Revenue Cost of revenue in each of our segments is comprised of the following: Veterinary invoice expense Veterinary invoice expense includes our costs to review and pay veterinary invoices, administer the payments, and provide member services, and other operating expenses directly or indirectly related to this process.
Total pets enrolled reflects the number of pets enrolled in one of the insurance products offered in our subscription business segment and our other business segment at the end of each period presented. We monitor total pets enrolled because it provides an indication of the growth of our consolidated business. Total subscription pets enrolled.
Total pets enrolled reflects the number of pets enrolled in one of the insurance products offered in our subscription business segment or our other business segment at the end of each period presented. We monitor total pets enrolled because it provides an indication of the growth of our consolidated business. Total subscription pets enrolled.
Technology and development Technology and development expenses primarily consist of personnel costs and related expenses for our technology staff, which includes information technology development and infrastructure support, including third-party services. It also includes expenses associated with development in new geographies and new products and offerings.
Technology and development Technology and development expenses primarily consist of personnel costs and related expenses for our technology staff, which includes information technology development, security, infrastructure support, and third-party services. It also includes expenses associated with development in new geographies and new products and offerings.
As our business grows, the amount of capital we are required to maintain to satisfy our risk-based capital requirements will also increase, though risk-based capital requirements also take our overall rate of growth into consideration. Recently, our other business segment growth has slowed and, currently, we expect that to continue, which would reduce capital requirements.
As our business in the U.S. grows, the amount of capital we are required to maintain to satisfy our risk-based capital requirements will also increase, though risk-based capital requirements also take our overall rate of growth into consideration. Recently, our other business segment growth has slowed and, we currently expect that to continue, which would reduce capital requirements.
We account for such expense as stock-based compensation in accordance with GAAP, but we do not include it in any non-GAAP adjustments. Stock-based compensation associated with bonuses was approximately $1.5 million and $1.3 million for the years ended December 31, 2024 and 2023, respectively.
We account for such expense as stock-based compensation in accordance with GAAP, but we do not include it in any non-GAAP adjustments. Stock-based compensation associated with bonuses was approximately $0.8 million, $1.5 million and $1.3 million for the years ended December 31, 2025, 2024 and 2023, respectively.
(3) Consists of costs related to product exploration and development that are pre-revenue and historically have been insignificant (4) Excludes the portion of stock-based compensation expense attributable to the other business segment 43 When determining our PAC, we calculate net acquisition cost for a more comparable metric across periods.
(2) Excludes the portion of stock-based compensation expense attributable to the other business segment (3) Consists of costs related to product exploration and development that are pre-revenue and historically have been insignificant 42 When determining our PAC, we calculate net acquisition cost for a more comparable metric across periods.
The NAIC requirements provide a method for analyzing the minimum amount of risk-based capital (statutory capital and surplus plus other adjustments) appropriate for an insurance company to support its overall business operations, taking into account the risk characteristics of the company’s assets, liabilities and certain other items .
These regulatory requirements provide a method for analyzing the minimum amount of capital (statutory capital and surplus plus other adjustments) appropriate for an insurance company to support its overall business operations, taking into account the risk characteristics of the company’s assets, liabilities and certain other items .
As such, our average monthly retention rate as of December 31, 2024 is an average of each month’s retention from January 1, 2024 through December 31, 2024.
As such, our average monthly retention rate as of December 31, 2025 is an average of each month’s retention from January 1, 2025 through December 31, 2025.
Overview We provide medical insurance for cats and dogs in the United States, Canada, certain countries in Continental Europe, and Australia. Through our data-driven, vertically-integrated approach, we develop and offer high value medical insurance products, priced specifically for each pet’s unique characteristics and coverage level. Our growing and loyal membership base provides us with highly predictable and recurring revenue.
Overview We provide medical insurance for cats and dogs in the United States, Canada, and certain countries in Continental Europe. Through our data-driven, vertically-integrated approach, we develop and offer high-value medical insurance products, priced to take into account each pet’s unique characteristics and coverage level. Our growing and loyal membership base provides us with highly predictable and recurring revenue.
This section of this Form 10-K generally discusses 2024 and 2023 items and year-to-year comparisons between 2024 and 2023.
This section of this Form 10-K generally discusses 2025 and 2024 items and year-to-year comparisons between 2025 and 2024.
Investing Cash Flows Net cash used by investing activities was $13.5 million for the year ended December 31, 2024, primarily consisting of $9.7 million of capital expenditures primarily related to the development of internal-use software focused on member experience, claims processing, and internal policy management improvements and $5.8 million in purchases, net of sales and maturities, of investment securities.
Net cash used in investing activities was $13.5 million for the year ended December 31, 2024, primarily consisting of purchases of investment securities of $133.5 million as well as $9.7 million of capital expenditures primarily related to the development of internal-use software focused on member experience, claims processing, and internal policy management improvements, partially offset by $127.7 million in sales and maturities of investment securities.
As required by the Office of the Superintendent of Financial Institutions regulations related to our reinsurance agreement with Accelerant Insurance Company of Canada, we are required to maintain a Canadian Trust account with the greater of CAD $2.0 million or 120% of unearned Canadian premium plus 20% of outstanding Canadian claims, including all incurred but not reported claims.
As required by OSFI regulations related to our reinsurance agreement with Accelerant, we are required to maintain a Canadian Reinsurance Trust account with the greater of CAD $2.0 million or 120% of unearned Canadian premium plus 20% of outstanding Canadian claims, including all incurred but not reported claims.
The ultimate liability, however, may be in excess of or less than the amount we have reserved. For the year ended December 31, 2024, we paid $60.1 million for veterinary invoices dated on or before December 31, 2023, including related processing costs. Our reserve estimate for these expenses was $63.2 million as of December 31, 2023.
The ultimate liability, however, may be in excess of or less than the amount we have reserved. For the year ended December 31, 2025, we paid $46.6 million for veterinary invoices dated on or before December 31, 2024, including related processing costs. Our reserve estimate for these expenses was $51.6 million as of December 31, 2024.
The 15% increase in veterinary invoice expense was driven by an increase in total subscription pet months for policies underwritten by Trupanion and a 7% increase in veterinary invoice expense per pet. The 17% increase in other cost of revenue was primarily driven by general increases in costs attributable to growth in our membership and subscription revenue.
The 12% increase in veterinary invoice expense was primarily driven by an 8% increase in veterinary invoice expense per pet and an increase in total subscription pet months for policies underwritten by Trupanion. The 10% increase in other cost of revenue was primarily due to general increases in costs attributable to growth in our membership and subscription revenue.
New pet acquisition expense New pet acquisition expenses primarily consist of costs, including personnel costs, to educate veterinarians and consumers about the benefits of Trupanion, to generate leads and to convert leads into enrolled pets, as well as print, online and promotional advertising costs.
New pet acquisition expense New pet acquisition expenses primarily consist of costs to acquire a pet (including costs associated directly to supporting the first year of a member), personnel costs, costs to educate veterinarians and consumers about the benefits of Trupanion, costs to generate leads and to convert leads into enrolled pets, as well as print, online and promotional advertising costs.
As of December 31, 2024, the account held CAD $19.9 million. WICL Segregated Account Trupanion Germany and WICL Segregated Account Trupanion Switzerland were established in the third quarter of 2024 by WICL, with Trupanion, Inc. as the shareholder, for purposes of entering into reinsurance agreements with underwriters in Germany and Switzerland, respectively.
WICL Segregated Account Trupanion Germany and WICL Segregated Account Trupanion Switzerland were established in the third quarter of 2024 by WICL, with Trupanion, Inc. as the shareholder, for purposes of entering into reinsurance agreements with underwriters in Germany and Switzerland, respectively.
(2) Consists of business acquisition transaction expenses, severance and legal costs due to certain executive departures, and a $3.8 million non-recurring settlement of accounts receivable in the first quarter of 2023 related to uncollected premiums in connection with the transition of underwriting a third-party business to other insurers.
(2) Excludes the portion of stock-based compensation expense attributable to the other business segment. (3) Consists of business acquisition transaction expenses, severance and legal costs due to certain executive departures, and a $3.8 million non-recurring settlement of accounts receivable in 2023 related to uncollected premiums in connection with the transition of underwriting a third-party business to other insurers.
Other cost of revenue Other cost of revenue for the subscription business segment includes direct and indirect member service expenses, Territory Partner fees upon policy renewals, payment processing fees and premium tax expenses.
Other cost of revenue Other cost of revenue for the subscription business segment includes direct and indirect member service expenses, Territory Partner commissions per member renewal, payment processing fees and premium tax expenses.
Most of the assets in our insurance entities are subject to certain capital and dividend rules and regulations prescribed by jurisdictions in which they are authorized to operate.
In addition to minimum capital requirements the majority of assets in our insurance entities are subject to dividend rules and regulations prescribed by jurisdictions in which they are authorized to operate.
General and Administrative Expenses Year Ended December 31, % Change 2024 2023 2022 2024 vs. 2023 2023 vs. 2022 (in thousands, except percentages) General and administrative $ 63,731 $ 60,207 $ 39,379 6% 53% Percentage of total revenue 5 % 5 % 4 % Year ended December 31, 2024 compared to year ended December 31, 2023.
General and Administrative Expenses Year Ended December 31, % Change 2025 2024 2023 2025 vs. 2024 2024 vs. 2023 (in thousands, except percentages) General and administrative $ 76,648 $ 63,731 $ 60,207 20% 6% Percentage of total revenue 5 % 5 % 5 % Year ended December 31, 2025 compared to year ended December 31, 2024.
New Pet Acquisition Expense Year Ended December 31, % Change 2024 2023 2022 2024 vs. 2023 2023 vs. 2022 (in thousands, except pet and per pet data) New pet acquisition expense $ 71,379 $ 77,372 $ 89,500 (8)% (14)% Percentage of total revenue 6 % 7 % 10 % Subscription Business: Total subscription pets enrolled (at period end) 1,041,212 991,426 869,862 5 14 Average pet acquisition cost (PAC) $ 235 $ 228 $ 289 3 (21) Year ended December 31, 2024 compared to year ended December 31, 2023.
New Pet Acquisition Expense Year Ended December 31, % Change 2025 2024 2023 2025 vs. 2024 2024 vs. 2023 (in thousands, except pet and per pet data) New pet acquisition expense $ 85,408 $ 71,379 $ 77,372 20% (8)% Percentage of total revenue 6 % 6 % 7 % Subscription Business: Total subscription pets enrolled (at period end) 1,096,173 1,041,212 991,426 5 5 Average pet acquisition cost (PAC) $ 288 $ 235 $ 228 23 3 Year ended December 31, 2025 compared to year ended December 31, 2024.
Cost of revenue for the other business segment increased from 92% to 93% of revenue year-over-year. 50 Technology and Development Expenses Year Ended December 31, % Change 2024 2023 2022 2024 vs. 2023 2023 vs. 2022 (in thousands, except percentages) Technology and development $ 31,255 $ 21,403 $ 25,133 46% (15)% Percentage of total revenue 2 % 2 % 3 % Year ended December 31, 2024 compared to year ended December 31, 2023.
Total cost of revenue for the other business segment decreased from 94% to 93% of revenue year-over-year. 49 Technology and Development Expenses Year Ended December 31, % Change 2025 2024 2023 2025 vs. 2024 2024 vs. 2023 (in thousands, except percentages) Technology and development $ 37,848 $ 31,255 $ 21,403 21% 46% Percentage of total revenue 3 % 2 % 2 % Year ended December 31, 2025 compared to year ended December 31, 2024.
Gain (loss) from investment in joint venture Gain (loss) from investment in joint venture consists of the share of income and losses from our equity method investment in a joint venture, as well as income and expenses associated with administrative services provided to the joint venture. Stock-based compensation Stock-based compensation is included in the cost and expense line items above.
Gain (loss) from investment in joint venture Gain (loss) from investment in joint venture consists of the share of income and losses from our equity method investment in a joint venture in Australia, as well as income and expenses associated with administrative services provided to the joint venture.
Net cash provided by investing activities was $7.6 million for the year ended December 31, 2023, primarily consisting of $24.3 million in sales and maturities of investment securities, net of purchases, offset by $18.3 million of capital expenditures primarily related to the development of internal-use software focused on member experience, claims processing, and internal policy management improvements.
Investing Cash Flows Net cash used in investing activities was $95.9 million for the year ended December 31, 2025, primarily consisting of purchases of investment securities of $256.0 million as well as $14.1 million of capital expenditures primarily related to the development of internal-use software focused on member experience, claims processing and internal policy management improvements, partially offset by $172.6 million in sales and maturities of investment securities.
This increase was primarily driven by a 17% increase in monthly average revenue per pet in this segment, partially offset by a decrease in pet months in this segment primarily reflecting the expected run off of pets we historically insured for a third-party. 49 Cost of Revenue Year Ended December 31, % Change 2024 2023 2022 2024 vs. 2023 2023 vs. 2022 (in thousands, except percentages, pet and per pet data) Cost of Revenue: Subscription business: Veterinary invoice expense $ 624,428 $ 543,196 $ 436,880 15% 24% Other cost of revenue 82,423 70,490 60,804 17 16 Total cost of revenue $ 706,851 $ 613,686 $ 497,684 15 23 Other business: Veterinary invoice expense $ 324,720 $ 287,859 $ 212,857 13 35 Other cost of revenue 75,315 76,044 72,453 (1) 5 Total cost of revenue $ 400,035 $ 363,903 $ 285,310 10 28 Percentage of Revenue by Segment: Subscription business: Veterinary invoice expense 73 % 76 % 73 % Other cost of revenue 10 10 10 Total cost of revenue 83 86 83 Other business: Veterinary invoice expense 76 73 69 Other cost of revenue 18 19 23 Total cost of revenue 94 92 92 Total pets enrolled (at period end) 1,677,570 1,714,473 1,537,573 (2) 12 Total subscription pets enrolled (at period end) 1,041,212 991,426 869,862 5 14 Monthly average revenue per pet $ 72.98 $ 65.26 $ 63.82 12 2 Year ended December 31, 2024 compared to year ended December 31, 2023.
This increase was primarily driven by a 20% increase in monthly average revenue per pet in this segment, partially offset by a decrease in pet months primarily reflecting the expected run-off of pets we historically insured for Pets Best. 48 Cost of Revenue Year Ended December 31, % Change 2025 2024 2023 2025 vs. 2024 2024 vs. 2023 (in thousands, except percentages, pet and per pet data) Cost of Revenue: Subscription business: Veterinary invoice expense $ 700,154 $ 624,428 $ 543,196 12% 15% Other cost of revenue 90,726 82,423 70,490 10 17 Total cost of revenue $ 790,880 $ 706,851 $ 613,686 12 15 Other business: Veterinary invoice expense $ 328,821 $ 324,720 $ 287,859 1 13 Other cost of revenue 88,593 75,315 76,044 18 (1) Total cost of revenue $ 417,414 $ 400,035 $ 363,903 4 10 Percentage of Revenue by Segment: Subscription business: Veterinary invoice expense 71 % 73 % 76 % Other cost of revenue 9 10 10 Total cost of revenue 80 83 86 Other business: Veterinary invoice expense 73 76 73 Other cost of revenue 20 18 19 Total cost of revenue 93 94 92 Total pets enrolled (at period end) 1,647,565 1,677,570 1,714,473 (2) (2) Total subscription pets enrolled (at period end) 1,096,173 1,041,212 991,426 5 5 Monthly average revenue per pet $ 80.79 $ 72.98 $ 65.26 11 12 Year ended December 31, 2025 compared to year ended December 31, 2024.
The following tables reconcile GAAP new pet acquisition expense to non-GAAP net acquisition cost (in thousands) for the years ended December 31, 2024, 2023, and 2022, and for each of the last eight fiscal quarters: Year Ended December 31, 2024 2023 2022 New pet acquisition expense $ 71,379 $ 77,372 $ 89,500 Net of sign-up fee revenue (4,061) (4,527) (4,984) Excluding: Stock-based compensation expense (6,908) (7,000) (9,116) Other business pet acquisition expense (39) (200) (541) Pet acquisition expense for commission-based policies (3,345) (3,443) (443) Net acquisition cost $ 57,026 $ 62,202 $ 74,416 Three Months Ended Dec. 31, 2024 Sep. 30, 2024 Jun. 30, 2024 Mar. 31, 2024 Dec. 31, 2023 Sep. 30, 2023 Jun. 30, 2023 Mar. 31, 2023 New pet acquisition expense $ 18,354 $ 18,308 $ 17,874 $ 16,843 $ 17,189 $ 17,772 $ 20,769 $ 21,642 Net of sign-up fee revenue (906) (1,100) (1,036) (1,019) (1,035) (1,084) (1,189) (1,219) Excluding: Stock-based compensation expense (1,482) (1,503) (2,066) (1,857) (1,567) (1,679) (1,722) (2,032) Other business pet acquisition expense (8) (8) (10) (13) (77) (10) (62) (51) Pet acquisition expense for commission-based policies (1,125) (634) (754) (832) (802) (826) (888) (927) Net acquisition cost $ 14,833 $ 15,063 $ 14,008 $ 13,122 $ 13,708 $ 14,173 $ 16,908 $ 17,413 Components of Operating Results General We operate in two reporting segments: subscription business and other business.
The following tables reconcile GAAP new pet acquisition expense to non-GAAP net acquisition cost (in thousands) for the years ended December 31, 2025, 2024, and 2023, and for each of the last eight fiscal quarters: Year Ended December 31, 2025 2024 2023 New pet acquisition expense $ 85,408 $ 71,379 $ 77,372 Net of sign-up fee revenue (4,307) (4,061) (4,527) Excluding: Stock-based compensation expense (1) (7,446) (6,908) (7,000) Other business pet acquisition expense (90) (39) (200) Pet acquisition expense for commission-based policies (3,184) (3,345) (3,443) Net acquisition cost $ 70,381 $ 57,026 $ 62,202 Three Months Ended Dec. 31, 2025 Sep. 30, 2025 Jun. 30, 2025 Mar. 31, 2025 Dec. 31, 2024 Sep. 30, 2024 Jun. 30, 2024 Mar. 31, 2024 New pet acquisition expense $ 23,103 $ 21,946 $ 19,843 $ 20,516 $ 18,354 $ 18,308 $ 17,874 $ 16,843 Net of sign-up fee revenue (1,049) (1,157) (1,061) (1,040) (906) (1,100) (1,036) (1,019) Excluding: Stock-based compensation expense (1) (1,530) (1,527) (1,516) (2,873) (1,482) (1,503) (2,066) (1,857) Other business pet acquisition expense (8) (5) (74) (3) (8) (8) (10) (13) Pet acquisition expense for commission-based policies (869) (790) (927) (598) (1,125) (634) (754) (832) Net acquisition cost $ 19,647 $ 18,467 $ 16,265 $ 16,002 $ 14,833 $ 15,063 $ 14,008 $ 13,122 Components of Operating Results General We operate in two reporting segments: subscription business and other business.
The 13% increase in veterinary invoice expense was primarily driven by a 21% increase in veterinary invoice expense per pet, offset by a decrease in pet months in this segment primarily reflecting the expected run off of pets we historically insured for a third-party. The 1% decrease in other cost of revenue was primarily driven by decreases in premium-based expenses.
The 1% increase in veterinary invoice expense was primarily driven by a 16% increase in veterinary invoice expense per pet, partially offset by a decrease in pet months in this segment primarily reflecting the expected run-off of pets we historically insured for Pets Best.
Total subscription pets enrolled reflects the number of pets in active memberships at the end of each period presented. We monitor total subscription pets enrolled because it provides an indication of the growth of our subscription business. Monthly average revenue per pet.
Total subscription pets enrolled reflects the number of pets enrolled in one of the insurance products offered in our subscription business segment at the end of each period presented. We monitor total subscription pets enrolled because it provides an indication of the growth of our subscription business.
Total Other Expense (Income), Net Year Ended December 31, % Change 2024 2023 2022 2024 vs. 2023 2023 vs. 2022 (in thousands, except percentages) Interest expense $ 14,498 $ 12,077 $ 4,267 20% 183% Other expense (income), net (14,374) (7,701) (3,072) 87 151 Total other (income) expense, net $ 124 $ 4,376 $ 1,195 (97)% 266% Percentage of total revenue — % — % — % Year ended December 31, 2024 compared to year ended December 31, 2023.
Total Other Expense (Income), Net Year Ended December 31, % Change 2025 2024 2023 2025 vs. 2024 2024 vs. 2023 (in thousands, except percentages) Interest expense $ 13,759 $ 14,498 $ 12,077 (5)% 20% Other (income), net (21,916) (14,374) (7,701) 52 87 Total other (income) expense, net $ (8,157) $ 124 $ 4,376 (6,678)% (97)% Percentage of total revenue 1 % — % — % Year ended December 31, 2025 compared to year ended December 31, 2024.
If our capital surplus grows relative to the rate of growth of our business, we may also generate cash for operations and growth, via dividends or other methods, from one or more of our underwriting entities.
Financing could include equity, equity-linked, or debt financing. Additional financing may not be available to us on acceptable terms, or at all. If our capital surplus grows relative to the rate of growth of our business, we may also generate cash for operations and growth, via dividends or other methods, from one or more of our underwriting entities.
Regulation As of December 31, 2024, our insurance entities collectively held $125.5 million in cash and cash equivalents, to be used for operating expenses of our insurance entities, $146.4 million in short-term investments and $270.2 million in other current assets.
As of December 31, 2025, our insurance entities collectively held $88.1 million in cash and cash equivalents, to be used for operating expenses of our insurance entities, $232.6 million in short-term investments and $299.6 million in other current assets.
Year Ended December 31, 2024 2023 2022 (in thousands) Revenue: Subscription business $ 856,521 $ 712,906 $ 596,610 Other business 429,163 395,699 308,569 Total revenue 1,285,684 1,108,605 905,179 Cost of revenue: Subscription business 706,851 613,686 497,684 Other business 400,035 363,903 285,310 Total cost of revenue (1) 1,106,886 977,589 782,994 Operating expenses: Technology and development (1) 31,255 21,403 25,133 General and administrative (1) 63,731 60,207 39,379 New pet acquisition expense (1) 71,379 77,372 89,500 Goodwill impairment charges 5,299 — — Depreciation and amortization 16,466 12,474 10,921 Total operating expenses 188,130 171,456 164,933 Gain (loss) from investment in joint venture (182) (219) (253) Operating loss (9,514) (40,659) (43,001) Interest expense 14,498 12,077 4,267 Other expense (income), net (14,374) (7,701) (3,072) Loss before income taxes (9,638) (45,035) (44,196) Income tax expense (benefit) (5) (342) 476 Net loss $ (9,633) $ (44,693) $ (44,672) (1) Includes stock-based compensation expense as follows: Year Ended December 31, 2024 2023 2022 (in thousands) Cost of revenue $ 5,523 $ 5,279 $ 6,484 Technology and development 4,934 2,846 4,742 General and administrative 15,696 17,717 12,831 New pet acquisition expense 7,279 7,319 9,336 Total stock-based compensation expense $ 33,432 $ 33,161 $ 33,393 47 Year Ended December 31, 2024 2023 2022 (as a percentage of revenue) Revenue 100 % 100 % 100 % Cost of revenue 86 88 87 Operating expenses: Technology and development 2 2 3 General and administrative 5 5 4 New pet acquisition expense 6 7 10 Goodwill impairment charges — — — Depreciation and amortization 1 1 1 Total operating expenses 14 15 18 Gain (loss) from investment in joint venture — — — Operating loss (1) (4) (5) Interest expense 1 1 — Other expense (income), net (1) (1) — Loss before income taxes (1) (4) (5) Income tax expense (benefit) — — — Net loss (1) % (4) % (5) % Stock-based compensation expense: Year Ended December 31, 2024 2023 2022 (as a percentage of revenue) Cost of revenue — % — % 1 % Technology and development — — % 1 General and administrative 1 2 % 1 New pet acquisition expense 1 1 % 1 Total stock-based compensation expense 2 % 3 % 4 % Year Ended December 31, 2024 2023 2022 (as a percentage of subscription revenue) Subscription business revenue 100 % 100 % 100 % Subscription business cost of revenue 83 86 83 48 Comparison of the years ended December 31, 2024, 2023, and 2022 Revenue Year Ended December 31, % Change 2024 2023 2022 2024 vs. 2023 2023 vs. 2022 (in thousands, except percentages, pet and per pet data) Revenue: Subscription business $ 856,521 $ 712,906 $ 596,610 20% 19% Other business 429,163 395,699 308,569 8 28 Total revenue $ 1,285,684 $ 1,108,605 $ 905,179 16 22 Percentage of Revenue by Segment: Subscription business 67 % 64 % 66 % Other business 33 36 34 Total revenue 100 % 100 % 100 % Total pets enrolled (at period end) 1,677,570 1,714,473 1,537,573 (2) 12 Total subscription pets enrolled (at period end) 1,041,212 991,426 869,862 5 14 Monthly average revenue per pet $ 72.98 $ 65.26 $ 63.82 12 2 Average monthly retention 98.25 % 98.49 % 98.69 % Year ended December 31, 2024 compared to year ended December 31, 2023.
Year Ended December 31, 2025 2024 2023 (in thousands) Revenue: Subscription business $ 989,338 $ 856,521 $ 712,906 Other business 449,967 429,163 395,699 Total revenue 1,439,305 1,285,684 1,108,605 Cost of revenue: Subscription business 790,880 706,851 613,686 Other business 417,414 400,035 363,903 Total cost of revenue (1) 1,208,294 1,106,886 977,589 Operating expenses: Technology and development (1) 37,848 31,255 21,403 General and administrative (1) 76,648 63,731 60,207 New pet acquisition expense (1) 85,408 71,379 77,372 Goodwill impairment charges 1,129 5,299 — Depreciation and amortization 15,836 16,466 12,474 Total operating expenses 216,869 188,130 171,456 Loss from investment in joint venture (305) (182) (219) Operating income (loss) 13,837 (9,514) (40,659) Interest expense 13,759 14,498 12,077 Other (income), net (21,916) (14,374) (7,701) Income (loss) before income taxes 21,994 (9,638) (45,035) Income tax expense (benefit) 2,561 (5) (342) Net income (loss) $ 19,433 $ (9,633) $ (44,693) (1) Includes stock-based compensation expense as follows: Year Ended December 31, 2025 2024 2023 (in thousands) Veterinary invoice expense (2) $ 2,841 $ 3,460 $ 3,667 Other cost of revenue (2) 2,284 2,063 1,612 Technology and development 6,036 4,934 2,846 General and administrative 19,571 15,696 17,717 New pet acquisition expense 7,580 7,279 7,319 Total stock-based compensation expense $ 38,312 $ 33,432 $ 33,161 (2) Veterinary invoice expense and Other cost of revenue together comprise stock-based compensation expense included within Total cost of revenue. 46 Year Ended December 31, 2025 2024 2023 (as a percentage of revenue) Revenue 100 % 100 % 100 % Cost of revenue 84 86 88 Operating expenses: Technology and development 3 2 2 General and administrative 5 5 5 New pet acquisition expense 6 6 7 Goodwill impairment charges — — — Depreciation and amortization 1 1 1 Total operating expenses 15 14 15 Loss from investment in joint venture — — — Operating income (loss) 1 (1) (4) Interest expense (1) 1 1 Other expense (income), net 2 (1) (1) Income (loss) before income taxes 2 (1) (4) Income tax expense (benefit) — — — Net income (loss) 2 % (1) % (4) % Stock-based compensation expense: Year Ended December 31, 2025 2024 2023 (as a percentage of revenue) Cost of revenue — % — % — % Technology and development — — — General and administrative 1 1 2 New pet acquisition expense 1 1 1 Total stock-based compensation expense 2 % 2 % 3 % Year Ended December 31, 2025 2024 2023 (as a percentage of subscription revenue) Subscription business revenue 100 % 100 % 100 % Subscription business cost of revenue 80 83 86 47 Comparison of the years ended December 31, 2025, 2024, and 2023 Revenue Year Ended December 31, % Change 2025 2024 2023 2025 vs. 2024 2024 vs. 2023 (in thousands, except percentages, pet and per pet data) Revenue: Subscription business $ 989,338 $ 856,521 $ 712,906 16% 20% Other business 449,967 429,163 395,699 5 8 Total revenue $ 1,439,305 $ 1,285,684 $ 1,108,605 12 16 Percentage of Revenue by Segment: Subscription business 69 % 67 % 64 % Other business 31 33 36 Total revenue 100 % 100 % 100 % Total pets enrolled (at period end) 1,647,565 1,677,570 1,714,473 (2) (2) Total subscription pets enrolled (at period end) 1,096,173 1,041,212 991,426 5 5 Monthly average revenue per pet $ 80.79 $ 72.98 $ 65.26 11 12 Average monthly retention 98.34 % 98.25 % 98.49 % Year ended December 31, 2025 compared to year ended December 31, 2024.
WICL Segregated Account AX was established by WICL, with Trupanion, Inc. as the shareholder, to enter into a reinsurance agreement with Accelerant Insurance Company of Canada, formerly known as Omega General Insurance Company.
WICL Segregated Account AX was established by WICL, with Trupanion, Inc. as the shareholder, to enter into a reinsurance agreement with Accelerant for our business activity in Canada.
Subscription payments are paid at the beginning of each subscription period. In most cases, our members authorize us to directly charge their credit card, debit card or bank account through automatic funds transfer. Subscription revenue is recognized on a pro rata basis over the policy term.
In most cases, our members authorize us to directly charge their credit card, debit card or bank account through automatic funds transfer. Subscription revenue is recognized on a pro rata basis over the policy term. Membership may be canceled at any time without penalty, and we issue a refund for the unused portion of the canceled membership.
Financing Cash Flows Net cash used by financing activities was $4.0 million for the year ended December 31, 2024, primarily consisting of $2.5 million in shares withheld to satisfy tax withholdings and $1.4 million in repayments on the Credit Facility.
Net cash used in financing activities was $4.0 million for the year ended December 31, 2024, primarily consisting of $2.5 million in shares withheld to satisfy tax withholdings and $1.4 million in repayments on the Prior Credit Facility. 54 Long-Term Debt Prior Credit Facility Our Prior Credit Facility provided us with up to $150.0 million of credit, and we had outstanding term loans totaling $116.2 million prior to repayment.
Year Ended December 31, 2024 2023 2022 Total Business: Total pets enrolled (at period end) 1,677,570 1,714,473 1,537,573 Subscription Business: Total subscription pets enrolled (at period end) 1,041,212 991,426 869,862 Monthly average revenue per pet $ 72.98 $ 65.26 $ 63.82 Average pet acquisition cost (PAC) $ 235 $ 228 $ 289 Average monthly retention 98.25 % 98.49 % 98.69 % Three Months Ended Dec. 31, 2024 Sep. 30, 2024 Jun. 30, 2024 Mar. 31, 2024 Dec. 31, 2023 Sep. 30, 2023 Jun. 30, 2023 Mar. 31, 2023 Total Business: Total pets enrolled (at period end) 1,677,570 1,688,903 1,699,643 1,708,017 1,714,473 1,712,177 1,679,659 1,616,865 Subscription Business: Total subscription pets enrolled (at period end) 1,041,212 1,032,042 1,020,934 1,006,168 991,426 969,322 943,958 906,369 Monthly average revenue per pet $ 76.02 $ 74.27 $ 71.72 $ 69.79 $ 67.07 $ 65.82 $ 64.41 $ 63.58 Average pet acquisition cost (PAC) $ 261 $ 243 $ 231 $ 207 $ 217 $ 212 $ 236 $ 247 Average monthly retention 98.25 % 98.29 % 98.34 % 98.41 % 98.49 % 98.55 % 98.61 % 98.65 % Total pets enrolled and total subscription pets enrolled include certain pet enrollments in European markets, where policies are currently underwritten by third parties and Trupanion is acting as an insurance broker.
Year Ended December 31, 2025 2024 2023 Total Business: Total pets enrolled (at period end) 1,647,565 1,677,570 1,714,473 Subscription Business: Total subscription pets enrolled (at period end) 1,096,173 1,041,212 991,426 Monthly average revenue per pet $ 80.79 $ 72.98 $ 65.26 Average pet acquisition cost (PAC) $ 288 $ 235 $ 228 Average monthly retention 98.34 % 98.25 % 98.49 % Three Months Ended Dec. 31, 2025 Sep. 30, 2025 Jun. 30, 2025 Mar. 31, 2025 Dec. 31, 2024 Sep. 30, 2024 Jun. 30, 2024 Mar. 31, 2024 Total Business: Total pets enrolled (at period end) 1,647,565 1,654,414 1,660,455 1,667,637 1,677,570 1,688,903 1,699,643 1,708,017 Subscription Business: Total subscription pets enrolled (at period end) 1,096,173 1,082,412 1,066,354 1,052,845 1,041,212 1,032,042 1,020,934 1,006,168 Monthly average revenue per pet $ 83.56 $ 82.01 $ 79.93 $ 77.53 $ 76.02 $ 74.27 $ 71.72 $ 69.79 Average pet acquisition cost (PAC) $ 320 $ 290 $ 276 $ 267 $ 261 $ 243 $ 231 $ 207 Average monthly retention 98.34 % 98.33 % 98.29 % 98.28 % 98.25 % 98.29 % 98.34 % 98.41 % Total pets enrolled and total subscription pets enrolled include certain pet enrollments in European markets, where policies are currently underwritten by third parties and Trupanion is acting as an insurance broker.
As of December 31, 2024, we had $307.4 million in cash, cash equivalents and short-term investments, of which $272.0 million was held by our insurance entities. Outside of insurance entities, we held $35.4 million in cash, cash equivalents and short-term investments with an additional $15.0 million available under our Credit Facility. Our insurance entities maintained $288.0 million of capital surplus.
As of December 31, 2025, we had $370.7 million in cash, cash equivalents and short-term investments, of which $320.7 million was held by our insurance entities. Outside of insurance entities, we held $50.0 million in cash, cash equivalents and short-term investments with an additional $5.0 million available under our PNC Facility.
All of the assets and liabilities of WICL Segregated Account Trupanion Germany and WICL Segregated Account Trupanion Switzerland are legally segregated from other assets and liabilities within WICL, and all shares of the segregated accounts are owned by Trupanion, Inc. 56 Though we are not directly regulated by the BMA, WICL's regulation and compliance impacts us as it could have an adverse impact on our ability to secure dividends from our WICL segregated accounts.
Though we are not directly regulated by the BMA, WICL's regulation and compliance impacts us as it could have an adverse impact on our ability to secure dividends from our WICL segregated accounts. WICL is regulated by the BMA under the Insurance Act of 1978 ("Insurance Act") and the Segregated Accounts Company Act of 2000.
This increase was primarily due to a 12% increase in monthly average revenue per pet and an increase in subscription pet months (the sum of pets enrolled for each month during a period) for policies underwritten by Trupanion. Revenue from our other business segment increased by $33.5 million, or 8%, to $429.2 million for the year ended December 31, 2024.
This increase was primarily due to an 11% increase in monthly average revenue per pet and an increase in subscription pet months (the sum of pets enrolled for each month during a period) for policies underwritten by Trupanion.
Depreciation and amortization expense increased by $4.0 million, or 32%, to $16.5 million for the year ended December 31, 2024 primarily driven by an increase in in-service internally developed software projects during the period.
Depreciation and amortization expense decreased by $0.6 million, or 4%, to $15.8 million for the twelve months ended December 31, 2025, primarily driven by fewer internally developed software projects placed in-service during the period.
A valuation allowance is recorded when it is more likely than not that the deferred tax asset will not be recovered. We apply judgment in the determination of the consolidated financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
We apply judgment in the determination of the consolidated financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
We define non-GAAP fixed expenses as the total of technology and development expense and general and administrative expense, less stock-based compensation expense, non-recurring transaction and restructuring expense, and development expenses related to exploring and developing new products and offerings that generally are in the pre-revenue stage or not at scale. 41 The following tables present the reconciliation of our non-GAAP financial measures from corresponding GAAP measures for the periods presented (in thousands): Year Ended December 31, 2024 2023 2022 Veterinary invoice expense $ 949,148 $ 831,055 $ 649,737 Less: Stock-based compensation expense (1) (3,335) (3,450) (4,054) Other business cost of paying veterinary invoices (4) (324,720) (287,858) (212,857) Subscription cost of paying veterinary invoices (non-GAAP) $ 621,093 $ 539,747 $ 432,826 % of subscription revenue 72.5 % 75.7 % 72.5 % Other cost of revenue $ 157,738 $ 146,534 $ 133,257 Less: Stock-based compensation expense (1) (1,955) (1,544) (2,232) Other business variable expenses (4) (75,050) (75,756) (72,453) Subscription variable expenses (non-GAAP) $ 80,733 $ 69,234 $ 58,572 % of subscription revenue 9.4 % 9.7 % 9.8 % Technology and development expense $ 31,255 $ 21,403 $ 25,133 General and administrative expense 63,731 60,207 39,379 Less: Stock-based compensation expense (1) (19,742) (19,869) (17,135) Non-recurring transaction or restructuring expenses (2) — (4,175) (372) Development expenses (3) (5,624) (5,100) (7,789) Fixed expenses (non-GAAP) $ 69,620 $ 52,466 $ 39,216 % of total revenue 5.4 % 4.7 % 4.3 % New pet acquisition expense $ 71,379 $ 77,372 $ 89,500 Less: Stock-based compensation expense (1) (6,908) (7,000) (9,116) Other business pet acquisition expense (4) (39) (200) (541) Subscription acquisition cost (non-GAAP) $ 64,432 $ 70,172 $ 79,843 % of subscription revenue 7.5 % 9.8 % 13.3 % (1) Trupanion employees may elect to take restricted stock units in lieu of cash payment for their bonuses.
Year Ended December 31, 2025 2024 2023 Veterinary invoice expense $ 1,028,975 $ 949,148 $ 831,055 Less: Stock-based compensation expense (1) (2,802) (3,335) (3,450) Other business cost of paying veterinary invoices (2) (328,821) (324,720) (287,858) Subscription cost of paying veterinary invoices (non-GAAP) $ 697,352 $ 621,093 $ 539,747 % of subscription revenue 70.5 % 72.5 % 75.7 % Other cost of revenue $ 179,319 $ 157,738 $ 146,534 Less: Stock-based compensation expense (1) (2,260) (1,955) (1,544) Other business variable expenses (2) (88,558) (75,050) (75,756) Subscription variable expenses (non-GAAP) $ 88,501 $ 80,733 $ 69,234 % of subscription revenue 8.9 % 9.4 % 9.7 % Technology and development expense $ 37,848 $ 31,255 $ 21,403 General and administrative expense 76,648 63,731 60,207 Less: Stock-based compensation expense (1) (24,958) (19,742) (19,869) Non-recurring transaction or restructuring expenses (3) — — (4,175) Development expenses (4) (5,349) (5,624) (5,100) Fixed expenses (non-GAAP) $ 84,189 $ 69,620 $ 52,466 % of total revenue 5.8 % 5.4 % 4.7 % New pet acquisition expense $ 85,408 $ 71,379 $ 77,372 Less: Stock-based compensation expense (1) (7,446) (6,908) (7,000) Other business pet acquisition expense (2) (90) (39) (200) Subscription acquisition cost (non-GAAP) $ 77,872 $ 64,432 $ 70,172 % of subscription revenue 7.9 % 7.5 % 9.8 % (1) Trupanion employees may elect to take restricted stock units in lieu of cash payment for their bonuses.
Within this segment, we also offer products in certain countries in Continental Europe, which are currently underwritten by third parties who pay us commissions that we recognize as revenue. Going forward our intent is to assume full insurance risk for these products, either through direct underwriting or reinsurance arrangements.
Within this segment, we also offer products in certain countries in Continental Europe, which are currently underwritten by third parties who pay us commissions that we recognize as revenue.
Total cost of revenue for our subscription business segment increased $93.2 million, or 15%, to $706.9 million for the year ended December 31, 2024. This increase was driven by a $81.2 million, or 15%, increase in veterinary invoice expense and a $11.9 million, or 17%, increase in other cost of revenue.
Total cost of revenue for our subscription business segment increased by $84.0 million, or 12%, to $790.9 million, for the twelve months ended December 31, 2025. This increase was driven by a $75.7 million, or 12%, increase in veterinary invoice expense and an $8.3 million, or 10%, increase in other cost of revenue.
Refer to Note 10, Debt, included in Item 8 of Part II of this report, for further details, including interest and future principal repayments. Critical Accounting Policies and Significant Estimates Our discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with GAAP.
Critical Accounting Policies and Significant Estimates Our discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with GAAP.
This increase was primarily due a $6.8 million reduction in capitalized expenditures related to internally-developed software projects launched in early 2024, a $1.0 million increase in general compensation and other employee-related expenses, a $1.3 million increase in infrastructure-related expenses, and an increase of $0.8 million in development expense.
This increase was primarily due to a $4.7 million increase in general compensation and other employee-related expenses, a $1.3 million reduction in capitalized expenditures related to internally developed software projects, and a $0.7 million increase in new product exploration and development expenses. Technology and development expenses increased from 2% to 3% of total revenue year-over-year.
The largest source of revenue within this segment is from our long-standing contractual relationship with Pets Best, a third-partner we have worked with since 2015. Additional products in this segment include the U.S. Department of Veterans Affairs program and employer-sponsored programs. Revenue We generate revenue in our subscription business segment primarily from subscription payments for our pet medical insurance.
This business segment has and targets, a significantly lower margin profile than our subscription business and is not part of our core business strategy. The largest source of revenue within this segment is from our long-standing contractual relationship with Pets Best, a third party insurance provider we have worked with since 2015. Additional products in this segment include the U.S.
New pet acquisition expense as a percentage of revenue was 6% for the year ended December 31, 2024 compared to 7% in the same period last year, as we were able to stay disciplined with our discretionary pet acquisition spend, while still managing to grow total enrolled subscription pets, excluding those related to managing general agent policies, by 5%. 51 Depreciation and Amortization Year Ended December 31, % Change 2024 2023 2022 2024 vs. 2023 2023 vs. 2022 (in thousands, except percentages) Depreciation and amortization $ 16,466 $ 12,474 $ 10,921 32% 14% Percentage of total revenue 1 % 1 % 1 % Year ended December 31, 2024 compared to year ended December 31, 2023.
New pet acquisition expense as a percentage of revenue remained constant at 6% as we were able to stay disciplined with our discretionary pet acquisition spend. 50 Depreciation and Amortization Year Ended December 31, % Change 2025 2024 2023 2025 vs. 2024 2024 vs. 2023 (in thousands, except percentages) Depreciation and amortization $ 15,836 $ 16,466 $ 12,474 (4)% 32% Percentage of total revenue 1 % 1 % 1 % Year ended December 31, 2025 compared to year ended December 31, 2024.
Sign-up fees are related to Trupanion’s obligation to provide insurance coverage and are recognized over the policy term. We also generate a portion of our subscription business segment revenue through commissions earned in our European markets, where policies are currently underwritten by third parties and Trupanion is acting as an insurance broker.
We also generate a portion of our subscription business segment revenue through commissions earned in certain European markets, where policies are currently underwritten by third parties and Trupanion is acting as an insurance broker. We generate revenue in our other business segment primarily from writing policies on behalf of third parties where we do not undertake direct consumer marketing.
The increase was primarily driven by a $36.9 million, or 13%, increase in veterinary invoice expense, partially offset by a $0.7 million, or 1%, decrease in other cost of revenue.
This increase was driven by a $4.1 million, or 1%, increase in veterinary invoice expense and a $13.3 million, or 18% increase in other cost of revenue.
Contractual Obligations We enter into long-term contractual obligations and commitments in the normal course of business, consisting primarily of debt obligations and non-cancellable vendor service agreements.
Contractual Obligations We enter into long-term contractual obligations and commitments in the normal course of business, consisting primarily of debt obligations and non-cancellable vendor service agreements. In November 2025, we entered into the PNC Agreement, which provides up to $120.0 million of credit, including $100.0 million term loan and $20.0 million revolving loan facility.
Membership may be canceled at any time without penalty, and we issue a refund for the unused portion of the canceled membership. In addition to subscription payments, we generate a small amount of revenue from charging a one-time sign-up fee to new members collected at the time of enrollment to partially offset initial setup costs.
In addition to subscription payments, we generate a small amount of revenue from charging a one-time sign-up fee collected at the time of new enrollment to partially offset initial setup costs. Sign-up fees are related to Trupanion’s obligation to provide insurance coverage and are recognized over the policy term.
Stock-based compensation will vary depending on corporate performance and terms of the awards under our equity incentive plan. For example, when we have delivered strong performance, stock-based compensation may increase as a result of incentive-based awards under our equity incentive plan. Factors Affecting Our Performance Average monthly retention.
For example, when we have delivered strong performance, stock-based compensation may increase as a result of incentive-based awards under our equity incentive plan. Factors Affecting Our Performance Average monthly retention. Our performance depends on our ability to continue to retain our existing and newly enrolled pets and is impacted by our ability to provide a best-in-class value and member experience.
All of the assets and liabilities of WICL Segregated Account AX are legally segregated from other assets and liabilities within WICL, and all shares of the segregated account are owned by Trupanion, Inc. In April 2024, our parent company received a dividend of $8.6 million from WICL Segregated Account AX as permitted under our agreements with WICL.
All of the assets and liabilities of WICL Segregated Account AX are legally segregated from other assets and liabilities within WICL, and all shares of the segregated account are owned by Trupanion, Inc.
Technology and development expenses increased by $9.9 million, or 46%, to $31.3 million for the year ended December 31, 2024.
Technology and development expenses increased by $6.6 million, or 21%, to $37.8 million for the twelve months ended December 31, 2025.
For further details on goodwill impairment charges refer to Note 4, Goodwill and Intangible Assets, included in Item 8 of this report. 45 Depreciation and amortization Depreciation and amortization expenses consist of depreciation of property, equipment, and software developed for internal use, as well as amortization of finite-lived intangible assets.
Depreciation and amortization Depreciation and amortization expenses consist of depreciation of property, equipment, and software developed for internal use, as well as amortization of finite-lived intangible assets.
This loss was subsequently determined to be recovered, and was reversed through other expense during the year ended December 31, 2024. Stock-Based Compensation Year ended December 31, 2024 compared to year ended December 31, 2023. Stock-based compensation is included in the cost and expense line items in the consolidated statements of operations, discussed above.
Stock-Based Compensation Year ended December 31, 2025 compared to year ended December 31, 2024. Stock-based compensation is included in the cost and expense line items in the consolidated statements of operations, discussed above. Stock-based compensation expense increased from $33.4 million to $38.3 million for the twelve months ended December 31, 2025.
Total revenue increased by $177.1 million, or 16%, to $1,285.7 million for the year ended December 31, 2024. Revenue from our subscription business segment increased by $143.6 million, or 20%, to $856.5 million for the year ended December 31, 2024.
Total revenue increased by $153.6 million, or 12%, to $1,439.3 million for the twelve months ended December 31, 2025. Revenue from our subscription business segment increased by $132.8 million, or 16%, to $989.3 million for the twelve months ended December 31, 2025.
Stock-based compensation expense in total was $33.4 million for the year ended December 31, 2024, an increase from $33.2 million in the prior year period. The amount of stock-based compensation recognized largely reflects the timing and vesting of our annual performance grants, calculated according to our equity incentive plan.
The amount of stock-based compensation recognized largely reflects the timing and vesting of our annual performance grants, calculated according to our equity incentive plan. 51 Quarterly Results of Operations The following tables contain selected quarterly financial information for the years ended December 31, 2025 and 2024.
Our “Territory Partners” travel through their territories to have face-to-face visits with veterinarians and their staff. Territory Partners are dedicated to cultivating direct veterinary relationships and helping those veterinarians understand the benefits of high-quality medical insurance.
Our “Territory Partners” create relationships with veterinary hospital teams through face-to-face visits. Territory Partners are dedicated to cultivating direct veterinary relationships and helping those veterinarians understand the benefits of high-quality medical insurance. Veterinarians then educate pet parents, who visit our website or call our contact center to learn more about, and potentially enroll in, a Trupanion product.
General and administrative expenses increased by $3.5 million, or 6%, to $63.7 million for the year ended December 31, 2024. This increase was driven by increases of $6.6 million in general compensation and other employee-related expenses, $2.7 million in professional services, and $2.3 million in underwriting fees related to our Canadian business.
This increase was driven by increases of $12.1 million in general compensation and other employee-related expenses and $1.9 million in underwriting fees related to our Canadian business, partially offset by a $0.8 million decrease in professional services and a $0.3 million decrease in other miscellaneous expenses. General and administrative expenses remained constant at 5% of total revenue year-over-year.
(4)Excludes the portion of stock-based compensation expense attributable to the other business segment. 42 Three Months Ended Dec. 31, 2024 Sep. 30, 2024 Jun. 30, 2024 Mar. 31, 2024 Dec. 31, 2023 Sep. 30, 2023 Jun. 30, 2023 Mar. 31, 2023 Veterinary invoice expense $ 245,663 $ 238,814 $ 231,102 $ 233,569 $ 217,739 $ 212,441 $ 206,738 $ 194,137 Less: Stock-based compensation expense (1) (800) (830) (843) (862) (885) (870) (856) (839) Other business cost of paying veterinary invoices (4) (85,378) (82,507) (75,622) (81,213) (77,572) (72,694) (72,443) (65,149) Subscription cost of paying veterinary invoices (non-GAAP) $ 159,485 $ 155,477 $ 154,637 $ 151,494 $ 139,282 $ 138,877 $ 133,439 $ 128,149 % of subscription revenue 70.0 % 71.0 % 74.1 % 75.3 % 72.7 % 75.9 % 77.0 % 77.6 % Other cost of revenue $ 38,721 $ 39,263 $ 43,429 $ 36,325 $ 38,054 $ 38,179 $ 34,455 $ 35,846 Less: Stock-based compensation expense (1) (476) (536) (523) (420) (386) (282) (428) (448) Other business variable expenses (4) (17,336) (18,126) (23,091) (16,498) (19,301) (20,482) (17,230) (18,743) Subscription variable expenses (non-GAAP) $ 20,909 $ 20,601 $ 19,815 $ 19,407 $ 18,367 $ 17,415 $ 16,797 $ 16,655 % of subscription revenue 9.2 % 9.4 % 9.5 % 9.6 % 9.6 % 9.5 % 9.7 % 10.1 % Technology and development expense $ 8,172 $ 7,933 $ 8,190 $ 6,960 $ 5,969 $ 5,302 $ 5,232 $ 4,900 General and administrative expense 16,828 16,977 15,253 14,673 13,390 12,664 13,136 21,017 Less: Stock-based compensation expense (1) (5,277) (5,258) (4,949) (4,258) (3,797) (3,754) (3,497) (8,821) Non-recurring transaction or restructuring expenses (2) — — — — — (8) (65) (4,102) Development expenses (3) (1,322) (1,474) (1,655) (1,178) (1,683) (1,594) (925) (898) Fixed expenses (non-GAAP) $ 18,401 $ 18,178 $ 16,839 $ 16,197 $ 13,879 $ 12,610 $ 13,881 $ 12,096 % of total revenue 5.5 % 5.6 % 5.3 % 5.3 % 4.7 % 4.4 % 5.1 % 4.7 % New pet acquisition expense $ 18,354 $ 18,308 $ 17,874 $ 16,843 $ 17,189 $ 17,772 $ 20,769 $ 21,642 Less: Stock-based compensation expense (1) (1,482) (1,503) (2,066) (1,857) (1,567) (1,679) (1,722) (2,032) Other business pet acquisition expense (4) (8) (8) (10) (13) (77) (10) (62) (51) Subscription acquisition cost (non-GAAP) $ 16,864 $ 16,797 $ 15,798 $ 14,973 $ 15,545 $ 16,083 $ 18,985 $ 19,559 % of subscription revenue 7.4 % 7.7 % 7.6 % 7.4 % 8.1 % 8.8 % 11.0 % 11.8 % (1) Trupanion employees may elect to take restricted stock units in lieu of cash payment for their bonuses.
(4) Consists of costs related to product exploration and development that are pre-revenue and historically have been insignificant 41 Three Months Ended Dec. 31, 2025 Sep. 30, 2025 Jun. 30, 2025 Mar. 31, 2025 Dec. 31, 2024 Sep. 30, 2024 Jun. 30, 2024 Mar. 31, 2024 Veterinary invoice expense $ 262,818 $ 263,127 $ 255,580 $ 247,450 $ 245,663 $ 238,814 $ 231,102 $ 233,569 Less: Stock-based compensation expense (1) (614) (666) (758) (763) (800) (830) (843) (862) Other business cost of paying veterinary invoices (2) (81,452) (85,394) (82,706) (79,269) (85,378) (82,507) (75,622) (81,213) Subscription cost of paying veterinary invoices (non-GAAP) $ 180,752 $ 177,067 $ 172,116 $ 167,418 $ 159,485 $ 155,477 $ 154,637 $ 151,494 % of subscription revenue 69.1 % 70.1 % 71.1 % 71.8 % 70.0 % 71.0 % 74.1 % 75.3 % Other cost of revenue $ 49,008 $ 43,739 $ 43,150 $ 43,422 $ 38,721 $ 39,263 $ 43,429 $ 36,325 Less: Stock-based compensation expense (1) (600) (579) (601) (482) (476) (536) (523) (420) Other business variable expenses (2) (25,589) (20,702) (20,531) (21,736) (17,336) (18,126) (23,091) (16,498) Subscription variable expenses (non-GAAP) $ 22,819 $ 22,458 $ 22,018 $ 21,204 $ 20,909 $ 20,601 $ 19,815 $ 19,407 % of subscription revenue 8.7 % 8.9 % 9.1 % 9.1 % 9.2 % 9.4 % 9.5 % 9.6 % Technology and development expense $ 11,303 $ 9,887 $ 8,586 $ 8,072 $ 8,172 $ 7,933 $ 8,190 $ 6,960 General and administrative expense 18,323 18,311 20,122 19,892 16,828 16,977 15,253 14,673 Less: Stock-based compensation expense (1) (6,617) (6,551) (6,393) (5,396) (5,277) (5,258) (4,949) (4,258) Development expenses (3) (1,798) (1,199) (946) (1,406) (1,322) (1,474) (1,655) (1,178) Fixed expenses (non-GAAP) $ 21,211 $ 20,448 $ 21,369 $ 21,162 $ 18,401 $ 18,178 $ 16,839 $ 16,197 % of total revenue 5.6 % 5.6 % 6.0 % 6.2 % 5.5 % 5.6 % 5.3 % 5.3 % New pet acquisition expense $ 23,103 $ 21,946 $ 19,843 $ 20,516 $ 18,354 $ 18,308 $ 17,874 $ 16,843 Less: Stock-based compensation expense (1) (1,530) (1,527) (1,516) (2,873) (1,482) (1,503) (2,066) (1,857) Other business pet acquisition expense (2) (8) (5) (74) (3) (8) (8) (10) (13) Subscription acquisition cost (non-GAAP) $ 21,565 $ 20,414 $ 18,253 $ 17,640 $ 16,864 $ 16,797 $ 15,798 $ 14,973 % of subscription revenue 8.2 % 8.1 % 7.5 % 7.6 % 7.4 % 7.7 % 7.6 % 7.4 % (1) Trupanion employees may elect to take restricted stock units in lieu of cash payment for their bonuses.
Development is favorable when losses ultimately settle for less than the amount reserved, or subsequent estimates indicate a basis for reducing loss reserves on unresolved claims. 57 As of December 31, 2024, our reserve for veterinary invoices was $51.6 million, consisting of $49.3 million for the amount we expect to pay in the future for veterinary invoices dated between January 1, 2024 and December 31, 2024, inclusive of related processing costs, and a reserve of $2.3 million for invoices dated prior to January 1, 2024.
As of December 31, 2025, our reserve for veterinary invoices was $55.9 million, consisting of $53.4 million for the amount we expect to pay in the future for veterinary invoices dated between January 1, 2025 and December 31, 2025, inclusive of related processing costs, and a reserve of $2.5 million for invoices dated prior to January 1, 2025.
We provide a full suite of services and support for these products and they are designed to align with the target margin profile of our subscription business segment. Within our subscription business segment we also offer products in certain countries in Continental Europe, which are underwritten by third parties who pay us commissions that we recognize as revenue.
Within this segment we also offer products in certain countries in Continental Europe, which are currently underwritten by third parties who pay us commissions that we recognize as revenue. 43 Our other business segment generates revenue from other product offerings, primarily by underwriting policies on behalf of third parties with whom we generally have a business-to-business relationship.
Our other business segment is comprised of revenue from other product offerings, with third parties with whom we generally have a business-to-business relationship. This business segment has, and targets, a lower margin profile than our subscription segment and is not part of our core business strategy.
This business segment has, and targets, a significantly lower margin profile than our subscription business segment and is not part of our core business strategy. The largest source of revenue within this segment is from our long-standing contractual relationship as an underwriter for Pets Best, a third-party insurance provider we have worked with since 2015.
An insurance company found to have insufficient statutory capital based on its risk-based capital ratio may be subject to varying levels of additional regulatory oversight depending on the level of capital inadequacy. APIC must hold certain capital amounts in order to comply with the statutory regulations and, therefore, we cannot use these amounts for general operating purposes without regulatory approval.
An insurance entity cannot use this capital for general operating expenses without regulatory approval. An insurance company found to have insufficient statutory capital based on its risk-based or minimum capital test requirements or otherwise fails to satisfy other applicable statutory requirements may be subject to varying levels of additional regulatory oversight.
Income Taxes We determine our deferred tax assets and liabilities based on the differences between the financial reporting and tax basis of assets and liabilities. The deferred tax assets and liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to reverse.
The deferred tax assets and liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that the deferred tax asset will not be recovered.